These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23341512)

  • 1. Refractory hypoglycemia controlled by sorafenib in solitary fibrous tumor.
    Le Jeune S; Des Guetz G; Bihan H; Cohen R; Coindre JM; Mourad JJ
    J Clin Oncol; 2013 Mar; 31(9):e118-21. PubMed ID: 23341512
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic management of metastatic medullary thyroid carcinoma: role of new tyrosine kinase inhibitors.
    García-Martín A; López-Ibarra Lozano PJ; Triviño-Ibáñez EM; Escobar-Jiménez F
    Endocrinol Nutr; 2013 Mar; 60(3):152-3. PubMed ID: 22565118
    [No Abstract]   [Full Text] [Related]  

  • 3. Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO).
    Valentin T; Fournier C; Penel N; Bompas E; Chaigneau L; Isambert N; Chevreau C
    Invest New Drugs; 2013 Dec; 31(6):1626-7. PubMed ID: 24005614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of retroperitoneal solitary fibrous tumor associated with hypoglycemia].
    Kawashima A; Ujike T; Nin M; Nishimura K; Miyoshi S; Kawano K; Go Y; Kitaoka H
    Hinyokika Kiyo; 2009 Jul; 55(7):395-9. PubMed ID: 19673425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemia in a patient with a huge malignant solitary fibrous tumor of the pleura.
    Chang JC; Su KY; Chao SF; Hsu YH; Yang GG; Chang BS
    Pathol Int; 2007 Dec; 57(12):791-3. PubMed ID: 17988280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solitary fibrous tumour of the pleura presenting with refractory non-insulin mediated hypoglycaemia (the Doege-Potter syndrome).
    Lee CE; Zanariah H; Masni M; Pau KK
    Med J Malaysia; 2010 Mar; 65(1):72-4. PubMed ID: 21265256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal malignant solitary fibrous tumor of the small pelvis causing recurrent hypoglycemia by secretion of insulin-like growth factor 2.
    Wagner S; Greco F; Hamza A; Hoda RM; Holzhausen HJ; Fornara P
    Eur Urol; 2009 Mar; 55(3):739-42. PubMed ID: 18848386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic atrophy--a new late toxic effect of sorafenib.
    Hescot S; Vignaux O; Goldwasser F
    N Engl J Med; 2013 Oct; 369(15):1475-6. PubMed ID: 24106956
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant solitary fibrous tumor with hypoglycemia (Doege-Potter syndrome).
    Yang CY; Chou CW; Hao LJ
    J Postgrad Med; 2013; 59(1):64-6. PubMed ID: 23525065
    [No Abstract]   [Full Text] [Related]  

  • 10. Solitary fibrous tumor in the pelvis: induced hypoglycemia associated with insulin-like growth factor II.
    Hosaka S; Katagiri H; Wasa J; Murata H; Takahashi M
    J Orthop Sci; 2015 Mar; 20(2):439-43. PubMed ID: 24019094
    [No Abstract]   [Full Text] [Related]  

  • 11. Pneumatosis intestinalis and hepatic portal venous gas in a patient receiving sorafenib.
    Kashima T; Ohno Y; Tachibana M
    Int J Urol; 2012 Nov; 19(11):1041-2. PubMed ID: 22788573
    [No Abstract]   [Full Text] [Related]  

  • 12. Sorafenib is effective in the treatment of pulmonary veno-occlusive disease.
    Kataoka M; Yanagisawa R; Fukuda K; Yoshino H; Satoh T
    Cardiology; 2012; 123(3):172-4. PubMed ID: 23128832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurring rare liver tumor presenting with hypoglycemia.
    Du EH; Walshe TM; Buckley AR
    Gastroenterology; 2015 Feb; 148(2):e11-3. PubMed ID: 25529805
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-islet cell tumour hypoglycaemia in a patient with a gastrointestinal stromal tumour.
    Rikhof B; Van Den Berg G; Van Der Graaf WT
    Acta Oncol; 2005; 44(7):764-6. PubMed ID: 16227170
    [No Abstract]   [Full Text] [Related]  

  • 15. Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: an experiment in vivo.
    Xu M; Xie XH; Xie XY; Xu ZF; Liu GJ; Zheng YL; Huang GL; Wang W; Zheng SG; Lü MD
    Acta Radiol; 2013 Mar; 54(2):199-204. PubMed ID: 23171528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large tumor of the liver and hypoglycemic shock in an 85-year-old patient.
    Radunz S; Baba HA; Sotiropoulos GC
    Gastroenterology; 2012 Feb; 142(2):e10-1. PubMed ID: 22198247
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial response of angiosarcoma of the scalp to sorafenib: association with decreased expression of vascular endothelial growth factors and their receptors.
    Tamiya H; Kamo R; Kumei A; Yanagihara S; Ishii M; Kobayashi H
    Clin Exp Dermatol; 2012 Oct; 37(7):749-52. PubMed ID: 22369131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.
    Bruix J; Raoul JL; Sherman M; Mazzaferro V; Bolondi L; Craxi A; Galle PR; Santoro A; Beaugrand M; Sangiovanni A; Porta C; Gerken G; Marrero JA; Nadel A; Shan M; Moscovici M; Voliotis D; Llovet JM
    J Hepatol; 2012 Oct; 57(4):821-9. PubMed ID: 22727733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally designed aberrant kinase-targeted endogenous protein nanomedicine against oncogene mutated/amplified refractory chronic myeloid leukemia.
    Retnakumari AP; Hanumanthu PL; Malarvizhi GL; Prabhu R; Sidharthan N; Thampi MV; Menon D; Mony U; Menon K; Keechilat P; Nair S; Koyakutty M
    Mol Pharm; 2012 Nov; 9(11):3062-78. PubMed ID: 22971013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovations in the treatment of melanoma.
    Pavlick AC
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-34-7. PubMed ID: 23570097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.